IPCALAB.NS Balance Sheet
Ipca Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹25.72 Bn | ₹43.40 Bn | ₹40.69 Bn | ₹44.41 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹1.22 Bn | ₹3.24 Bn | ₹6.16 Bn | ₹7.62 Bn | CapitalWorkInProgress |
| Goodwill | ₹0.38 Bn | ₹0.91 Bn | ₹0.91 Bn | ₹0.83 Bn | Goodwill |
| Other Intangible Assets | ₹1.41 Bn | ₹1.23 Bn | ₹1.07 Bn | ₹1.03 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹1.73 Bn | ₹1.47 Bn | ₹0.25 Bn | ₹0.27 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹0.52 Bn | ₹1.84 Bn | ₹2.38 Bn | ₹2.53 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹34.37 Bn | ₹55.62 Bn | ₹54.92 Bn | ₹59.93 Bn | NoncurrentAssets |
| Inventories | ₹17.43 Bn | ₹24.71 Bn | ₹25.60 Bn | ₹27.31 Bn | Inventories |
| Trade Receivables | ₹9.89 Bn | ₹16.87 Bn | ₹18.74 Bn | ₹20.14 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹12.58 Bn | ₹2.09 Bn | ₹1.67 Bn | ₹4.37 Bn | CashAndCashEquivalents |
| Current Investments | ₹3.23 Bn | ₹5.58 Bn | ₹7.63 Bn | ₹6.33 Bn | CurrentInvestments |
| Other Current Assets | ₹1.79 Bn | ₹4.36 Bn | ₹3.44 Bn | ₹3.63 Bn | OtherCurrentAssets |
| Total Current Assets | ₹51.89 Bn | ₹55.36 Bn | ₹59.67 Bn | ₹63.74 Bn | CurrentAssets |
| Total Assets | ₹86.26 Bn | ₹111.01 Bn | ₹117.61 Bn | ₹123.70 Bn | Assets |
| Equity Share Capital | ₹0.25 Bn | ₹0.25 Bn | ₹0.25 Bn | ₹0.25 Bn | EquityShareCapital |
| Other Equity | ₹58.17 Bn | ₹63.07 Bn | ₹69.23 Bn | ₹80.38 Bn | OtherEquity |
| Equity Attributable to Owners | ₹58.42 Bn | ₹63.32 Bn | ₹69.48 Bn | ₹80.64 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.73 Bn | ₹13.95 Bn | ₹14.40 Bn | ₹14.60 Bn | NonControllingInterest |
| Total Equity | ₹59.15 Bn | ₹77.27 Bn | ₹83.88 Bn | ₹95.24 Bn | Equity |
| Long-term Borrowings | ₹6.52 Bn | ₹5.80 Bn | ₹5.43 Bn | ₹1.09 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹9.05 Bn | ₹10.19 Bn | ₹9.86 Bn | ₹5.39 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹8.06 Bn | ₹8.07 Bn | ₹7.58 Bn | ₹5.95 Bn | BorrowingsCurrent |
| Trade Payables | ₹5.25 Bn | ₹7.76 Bn | ₹8.46 Bn | ₹9.40 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹0.69 Bn | ₹1.22 Bn | ₹0.87 Bn | ₹0.87 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹18.06 Bn | ₹23.56 Bn | ₹23.84 Bn | ₹23.07 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹86.26 Bn | ₹111.01 Bn | ₹117.61 Bn | ₹123.70 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from IPCALAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).